Georgia Hardavella
Overview
Explore the profile of Georgia Hardavella including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
62
Citations
537
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Asmara O, Hardavella G, Ramella S, Petersen R, Tietzova I, Boerma E, et al.
Breathe (Sheff)
. 2024 Oct;
20(3):240047.
PMID: 39360027
Stage III nonsmall cell lung cancer (NSCLC) represents a wide range of tumour (T1 to T4) and nodal (N0 to N3) components, requiring variable management and a multidisciplinary approach. Recent...
2.
Peeters S, Lau K, Stefanidis K, Yasufuku K, Ishiwata T, Rolfo C, et al.
Lung Cancer
. 2024 Sep;
196:107952.
PMID: 39236577
This paper highlights developments in diagnostic and nonsurgical local treatment modalities that have changed the management of early-stage lung cancer. These innovations aim to enhance diagnostic accuracy, minimize invasiveness, and...
3.
Hardavella G, Chorostowska-Wynimko J, Blum T
Breathe (Sheff)
. 2024 Aug;
20(2):240117.
PMID: 39193461
https://bit.ly/3XQexmp.
4.
Hardavella G, Magouliotis D, Chalela R, Januszewski A, Dennstaedt F, Putora P, et al.
Breathe (Sheff)
. 2024 Aug;
20(2):230219.
PMID: 39193460
Chest radiography, computed tomography (CT) and positron emission tomography (PET)-CT are required for staging nonsmall cell lung cancers. Stage I cancers may be up to 4 cm in maximal diameter,...
5.
Hardavella G, Frille A, Sreter K, Atrafi F, Yousaf-Khan U, Beyaz F, et al.
Breathe (Sheff)
. 2024 Aug;
20(2):230190.
PMID: 39193459
Lung cancer screening (LCS) programmes have emerged over recent years around the world. LCS programmes present differences in delivery, inclusion criteria and resource allocation. On a national scale, only a...
6.
Rozman A, Grabczak E, George V, Malovrh M, Novais Bastos H, Trojnar A, et al.
Breathe (Sheff)
. 2024 Aug;
20(2):230201.
PMID: 39193456
Interventional bronchoscopy has seen significant advancements in recent decades, particularly in the context of lung cancer. This method has expanded not only diagnostic capabilities but also therapeutic options. In this...
7.
Hardavella G, Carlea F, Karampinis I, Patirelis A, Athanasiadi K, Lioumpas D, et al.
Breathe (Sheff)
. 2024 Aug;
20(2):240046.
PMID: 39193455
Lung cancer surgery with curative intent has significantly developed over recent years, mainly focusing on minimally invasive approaches that do not compromise medical efficiency and ensure a decreased burden on...
8.
Fergadis E, Heitmann A, Tsaras T, Hardavella G
Breathe (Sheff)
. 2024 Aug;
20(2):240035.
PMID: 39193454
Adjuvant platinum-based chemotherapy has been the main treatment following surgical resection with curative intent in early and locally advanced nonsmall cell lung cancer (NSCLC) albeit with a 5% improvement in...
9.
Charpidou A, Hardavella G, Boutsikou E, Panagiotou E, Omeroglu Simsek G, Verbeke K, et al.
Breathe (Sheff)
. 2024 Jul;
20(2):230192.
PMID: 39015659
The progress in lung cancer treatment is closely interlinked with the progress in diagnostic methods. There are four steps before commencing lung cancer treatment: estimation of the patient's performance status,...
10.
Hardavella G, Frille A, Chalela R, Sreter K, Petersen R, Novoa N, et al.
Eur Respir Rev
. 2024 Jun;
33(172).
PMID: 38925794
Introduction: Implementation of lung cancer screening, with its subsequent findings, is anticipated to change the current diagnostic and surgical lung cancer landscape. This review aimed to identify and present the...